Viking Therapeutics' investigational obesity pill VK2735 achieved over 12% body weight reduction at 13 weeks in a Phase II trial. However, the tria...
Anixa Biosciences has treated the second patient in the fourth cohort of its Phase 1 clinical trial for ovarian cancer CAR-T therapy. The trial, co...
In the face of evolving digital threats, organizations are increasingly adopting cryptoagility as a strategic approach to enhance digital resilienc...
Kevin Spacey is set to attend the Venice Film Festival to promote his directorial comeback, 'Holiguards Saga — The Portal Of Force.' The sci-fi thr...
Nnamdi Asomugha, a former NFL player, has transitioned into filmmaking with his directorial debut, 'The Knife.' The psychological thriller, which o...
Tatcha has introduced The Longevity Serum, a new skincare innovation inspired by the longevity practices of Okinawa residents. The serum, developed...
The Vicksburg-Warren Chamber of Commerce has initiated a workforce development program in collaboration with Millsaps College Else School of Manage...
Blink Charging has reported its second-quarter earnings for Fiscal Year 2025, showing a loss of $0.26 per share, missing analysts' expectations of ...
Missouri Governor Mike Kehoe has announced a series of investments aimed at fostering a business-friendly environment in the state. The FY 2026 bud...
Ituran Location and Control Ltd. announced its Q2 2025 financial results, reporting a revenue increase to $86.8 million, up 2% year-over-year. The ...